Data for this review were identified by searches of Medline, Current Contents, and the Cochrane Database, and by reviewing the bibliographies of papers retrieved using this strategy. All articles published after 1966 were considered, as were articles in all languages. Search terms were “HIV”, “STD”, “STI” “syphilis”, “neurosyphilis”, “ocular”, “uveitis”, “retinitis”, “vitritis”, “cardiovascular”, “bone”, “skin”, “congenital”, and “malignant”. The websites of the World Health Organization,
ReviewSyphilis and HIV: a dangerous combination
Section snippets
Epidemiology
WHO estimates that approximately 349 million people are actively infected with a treatable sexually transmitted disease.6 Of these, estimates from 1999 suggest an annual rate for syphilis of approximately 12 million active infections6 Almost two-thirds of these cases are in sub-Saharan Africa and south/southeast Asia. Recent outbreaks have been reported from many countries on all continents.7, 8, 9, 10 In sub-Saharan Africa between 2 and 17% of women test positive for syphilis in antenatal
Diagnosis
The key to syphilis recognition is a full examination by a skilled medical practitioner familiar with the protean manifestations of the infection. This examination should include all of the skin and mouth as well as the genital region. If syphilis is not suspected then the opportunity for early diagnosis and treatment and public-health intervention will be lost.
Clinical manifestations of syphilis in the HIV-positive patient
Typically syphilis occurs in three phases—namely primary, secondary, and tertiary disease. However, this is a gross oversimplification and the clinical presentation of syphilis is extremely variable over many years (figure 2).4 Several differences have been reported in the manifestations of syphilis in HIV-positive patients. In particular there seems to be a shift from presentation with primary to secondary disease and more aggressive disease progression. Furthermore, HIV itself or
Treatment of syphilis
Penicillin remains the mainstay of therapy for all stages and sites of syphilis and in all patient groups.105, 106, 137 Guidelines vary (table 2) but the general principle is one of maintaining prolonged serum treponemocidal concentrations. In HIV-negative patients with early syphilis (less than 2 years' duration) it is not necessary either to investigate for neurosyphilis or to use therapy that achieves treponemocidal concentrations of antibiotics in CSF (table 2).20, 105 For example, CDC
Future prospects
So what does the future hold? It is remarkable that penicillin remains the mainstay of therapy and there is little prospect that newer antibiotics will displace penicillin in the near future particularly following the emergence of macrolide resistance. An effective vaccine would offer great hope but insufficient research efforts have directed against syphilis. Despite some success143 our understanding of the determinants of protective immunity to T palllidum remain poor with little prospect for
Search strategy and selection criteria
References (143)
- et al.
Forgotten but not gone: the continuing scourge of congenital syphilis
Lancet Infect Dis
(2002) - et al.
Sexually transmitted diseases in 1161 HIV-positive patients: a 38-month prospective study in southern Spain
J Eur Acad Dermatol Venereol
(1998) - et al.
Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: evidence for frequent serologic relapse after therapy
Am J Med
(1995) - et al.
Generalized macular rash with palmar-plantar involvement associated with lymphadenopathies. Secondary lues
Rev Clin Esp
(2001) - et al.
Cutaneous lesions of secondary syphilis are highly angiogenic
J Am Acad Dermatol
(2003) Syphilitic arthritis and osteitis
Rheum Dis Clin North Am
(1993)Sexually transmitted arthritis syndromes
Med Clin North Am
(1990)Syphilis in clinical psychiatry: a review
Psychosomatics
(2001)- et al.
Infect Dis Clin North Am
(1994) - et al.
Meningovascular neurosyphilis in human immunodeficiency virus infection as a differential diagnosis of focal CNS lesions: a clinicopathological study
J Infect
(1993)